Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as edotecarin and cisplatin, use different ways
to stop tumor cells from dividing so they stop growing or die. Combining edotecarin with
cisplatin may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of combining edotecarin with cisplatin in
treating patients who have advanced or metastatic solid tumors.